ID   PI3R5_HUMAN             Reviewed;         880 AA.
AC   Q8WYR1; B0LPH4; D3DTS3; Q5G936; Q5G938; Q5G939; Q8IZ23; Q9Y2Y2;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   12-APR-2017, entry version 113.
DE   RecName: Full=Phosphoinositide 3-kinase regulatory subunit 5;
DE            Short=PI3-kinase regulatory subunit 5;
DE   AltName: Full=PI3-kinase p101 subunit;
DE   AltName: Full=Phosphatidylinositol 4,5-bisphosphate 3-kinase regulatory subunit;
DE            Short=PtdIns-3-kinase regulatory subunit;
DE   AltName: Full=Protein FOAP-2;
DE   AltName: Full=PtdIns-3-kinase p101;
DE   AltName: Full=p101-PI3K;
GN   Name=PIK3R5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Yazaki M., Fujii Y., Tsuritani K., Yajima Y., Amemiya T., Ukai Y.,
RA   Naito K., Kawaguchi A., Takayama K.;
RT   "Molecular cloning of a human novel gene, FOAP-2, which are highly
RT   expressed in macrophages.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Stephens L., Hawkins P.T., Braselmann S.;
RT   "G-beta gamma regulated phosphatidylinositol 3-kinase.";
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-369 (ISOFORM 1).
RC   TISSUE=Peripheral blood leukocyte, and Spleen;
RA   Reichwald K., Gausmann U., Karagyozov L., Platzer M.;
RT   "Identification of alternative transcripts of human P101-PI3K.";
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INTERACTION WITH PIK3CG, AND TISSUE SPECIFICITY.
RX   PubMed=15797027; DOI=10.1016/j.cub.2005.02.020;
RA   Suire S., Coadwell J., Ferguson G.J., Davidson K., Hawkins P.,
RA   Stephens L.;
RT   "p84, a new Gbetagamma-activated regulatory subunit of the type IB
RT   phosphoinositide 3-kinase p110gamma.";
RL   Curr. Biol. 15:566-570(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458 AND SER-507, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   TISSUE SPECIFICITY, AND VARIANT AOA3 SER-629.
RX   PubMed=22065524; DOI=10.1002/humu.21650;
RA   Tassan N.A., Khalil D., Shinwari J., Sharif L.A., Bavi P.,
RA   Abduljaleel Z., Abu Dhaim N., Magrashi A., Bobis S., Ahmed H.,
RA   Alahmed S., Bohlega S.;
RT   "A missense mutation in PIK3R5 gene in a family with ataxia and
RT   oculomotor apraxia.";
RL   Hum. Mutat. 33:351-354(2012).
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] CYS-28.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Regulatory subunit of the PI3K gamma complex. Required
CC       for recruitment of the catalytic subunit to the plasma membrane
CC       via interaction with beta-gamma G protein dimers. Required for G
CC       protein-mediated activation of PIK3CG (By similarity).
CC       {ECO:0000250}.
CC   -!- ENZYME REGULATION: Greatly activated by G gamma proteins.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer of a catalytic subunit (PIK3CG/p120) and a
CC       regulatory (PIK3R5a/p101) subunit. Interacts with beta-gamma G
CC       protein dimers. {ECO:0000269|PubMed:15797027}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O02696}.
CC       Cytoplasm {ECO:0000250|UniProtKB:O02696}. Cell membrane
CC       {ECO:0000250|UniProtKB:O02696}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:O02696}. Note=Predominantly localized in
CC       the nucleus in absence of PIK3CG/p120. Colocalizes with
CC       PIK3CG/p120 in the cytoplasm. Translocated to the plasma membrane
CC       in a beta-gamma G protein-dependent manner.
CC       {ECO:0000250|UniProtKB:O02696}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8WYR1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WYR1-2; Sequence=VSP_016388;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed with high expression in
CC       fetal brain compared to adult brain. Abundant expression is
CC       observed in cerebellum, cerebral cortex, cerebral meninges, and
CC       vermis cerebelli. {ECO:0000269|PubMed:15797027,
CC       ECO:0000269|PubMed:22065524}.
CC   -!- DOMAIN: The heterodimerization region allows the binding to the
CC       catalytic subunit.
CC   -!- DISEASE: Ataxia-oculomotor apraxia 3 (AOA3) [MIM:615217]: An
CC       autosomal recessive disease characterized by cerebellar ataxia,
CC       oculomotor apraxia, areflexia and peripheral neuropathy.
CC       {ECO:0000269|PubMed:22065524}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB028925; BAB82464.1; -; mRNA.
DR   EMBL; AF128881; AAD33397.1; -; mRNA.
DR   EMBL; EU332864; ABY87553.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90035.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90036.1; -; Genomic_DNA.
DR   EMBL; BC028212; AAH28212.1; -; mRNA.
DR   EMBL; AY725851; AAW63121.1; -; mRNA.
DR   EMBL; AY725852; AAW63122.1; -; mRNA.
DR   EMBL; AY725853; AAW63123.1; -; mRNA.
DR   EMBL; AY725854; AAW63124.1; -; mRNA.
DR   CCDS; CCDS11147.1; -. [Q8WYR1-1]
DR   CCDS; CCDS73986.1; -. [Q8WYR1-2]
DR   RefSeq; NP_001136105.1; NM_001142633.2. [Q8WYR1-1]
DR   RefSeq; NP_001238780.1; NM_001251851.1. [Q8WYR1-2]
DR   RefSeq; NP_001238781.1; NM_001251852.1. [Q8WYR1-2]
DR   RefSeq; NP_001238782.1; NM_001251853.1. [Q8WYR1-2]
DR   RefSeq; NP_001238784.1; NM_001251855.1. [Q8WYR1-2]
DR   RefSeq; NP_055123.2; NM_014308.3. [Q8WYR1-1]
DR   UniGene; Hs.278901; -.
DR   UniGene; Hs.738684; -.
DR   ProteinModelPortal; Q8WYR1; -.
DR   SMR; Q8WYR1; -.
DR   BioGrid; 117079; 6.
DR   IntAct; Q8WYR1; 7.
DR   STRING; 9606.ENSP00000392812; -.
DR   BindingDB; Q8WYR1; -.
DR   ChEMBL; CHEMBL3559703; -.
DR   iPTMnet; Q8WYR1; -.
DR   PhosphoSitePlus; Q8WYR1; -.
DR   BioMuta; PIK3R5; -.
DR   DMDM; 74716480; -.
DR   MaxQB; Q8WYR1; -.
DR   PaxDb; Q8WYR1; -.
DR   PeptideAtlas; Q8WYR1; -.
DR   PRIDE; Q8WYR1; -.
DR   Ensembl; ENST00000447110; ENSP00000392812; ENSG00000141506. [Q8WYR1-1]
DR   Ensembl; ENST00000581552; ENSP00000462433; ENSG00000141506. [Q8WYR1-1]
DR   Ensembl; ENST00000611902; ENSP00000477795; ENSG00000141506. [Q8WYR1-2]
DR   Ensembl; ENST00000616147; ENSP00000484211; ENSG00000141506. [Q8WYR1-2]
DR   Ensembl; ENST00000623421; ENSP00000485280; ENSG00000141506. [Q8WYR1-2]
DR   GeneID; 23533; -.
DR   KEGG; hsa:23533; -.
DR   UCSC; uc002glt.4; human. [Q8WYR1-1]
DR   CTD; 23533; -.
DR   DisGeNET; 23533; -.
DR   GeneCards; PIK3R5; -.
DR   H-InvDB; HIX0027111; -.
DR   HGNC; HGNC:30035; PIK3R5.
DR   HPA; HPA044505; -.
DR   HPA; HPA052247; -.
DR   HPA; HPA052412; -.
DR   MalaCards; PIK3R5; -.
DR   MIM; 611317; gene.
DR   MIM; 615217; phenotype.
DR   neXtProt; NX_Q8WYR1; -.
DR   OpenTargets; ENSG00000141506; -.
DR   Orphanet; 64753; Spinocerebellar ataxia with axonal neuropathy type 2.
DR   PharmGKB; PA134890823; -.
DR   eggNOG; ENOG410IES2; Eukaryota.
DR   eggNOG; ENOG410Y2ZG; LUCA.
DR   GeneTree; ENSGT00530000063753; -.
DR   HOVERGEN; HBG079651; -.
DR   InParanoid; Q8WYR1; -.
DR   KO; K21290; -.
DR   OMA; TTEIFIH; -.
DR   OrthoDB; EOG091G01F0; -.
DR   PhylomeDB; Q8WYR1; -.
DR   TreeFam; TF102035; -.
DR   BioCyc; MetaCyc:HS13887-MONOMER; -.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-HSA-392451; G beta:gamma signalling through PI3Kgamma.
DR   ChiTaRS; PIK3R5; human.
DR   GeneWiki; PIK3R5; -.
DR   GenomeRNAi; 23533; -.
DR   PRO; PR:Q8WYR1; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000141506; -.
DR   CleanEx; HS_PIK3R5; -.
DR   ExpressionAtlas; Q8WYR1; baseline and differential.
DR   Genevisible; Q8WYR1; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005942; C:phosphatidylinositol 3-kinase complex; IBA:GO_Central.
DR   GO; GO:0005944; C:phosphatidylinositol 3-kinase complex, class IB; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0046935; F:1-phosphatidylinositol-3-kinase regulator activity; IBA:GO_Central.
DR   GO; GO:0031683; F:G-protein beta/gamma-subunit complex binding; ISS:UniProtKB.
DR   GO; GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0014065; P:phosphatidylinositol 3-kinase signaling; ISS:UniProtKB.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; ISS:UniProtKB.
DR   InterPro; IPR019522; PIK3R5/6.
DR   Pfam; PF10486; PI3K_1B_p101; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell membrane; Complete proteome;
KW   Cytoplasm; Disease mutation; Membrane; Neurodegeneration; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    880       Phosphoinositide 3-kinase regulatory
FT                                subunit 5.
FT                                /FTId=PRO_0000058421.
FT   REGION       25    101       Heterodimerization. {ECO:0000250}.
FT   REGION      653    753       Interaction with beta-gamma G protein
FT                                dimers. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000250|UniProtKB:O02696}.
FT   MOD_RES     458    458       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     507    507       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   VAR_SEQ       1    386       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016388.
FT   VARIANT      28     28       R -> C (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs371789171).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036227.
FT   VARIANT     629    629       P -> S (in AOA3; dbSNP:rs61761068).
FT                                {ECO:0000269|PubMed:22065524}.
FT                                /FTId=VAR_067052.
FT   CONFLICT     15     15       H -> L (in Ref. 6; AAW63122).
FT                                {ECO:0000305}.
FT   CONFLICT     29     29       R -> C (in Ref. 6; AAW63122).
FT                                {ECO:0000305}.
FT   CONFLICT     47     47       L -> Q (in Ref. 6; AAW63122).
FT                                {ECO:0000305}.
FT   CONFLICT     95     95       F -> L (in Ref. 6; AAW63122).
FT                                {ECO:0000305}.
FT   CONFLICT    171    171       V -> E (in Ref. 6; AAW63122).
FT                                {ECO:0000305}.
FT   CONFLICT    220    297       AKTLAELEDIFTETAEAQELASGIGDAAEARRWLRTKLQAV
FT                                GEKAGFPGVLDTAKPGKLHTIPIPVARCYTYSWSQDS ->
FT                                TLQNQGSSIPSPSLSPGATPTAGARTALTSCRKSCSRNRSC
FT                                SSQGSWEMMKRRKRRRRRWRRTWKLMGTVPREIPCSP (in
FT                                Ref. 6; AAW63122). {ECO:0000305}.
FT   CONFLICT    299    368       DILQEILLKEQELLQPGILGDDEEEEEEEEEVEEDLETDGH
FT                                CAERDSLLSTSSLASHDSTLSLASSQASG -> GNIEGDPG
FT                                PRRPDSAGLASLQTSCRKSCSRNRSYSSQGSWEMMKRRERR
FT                                RRRWRRTWKLTGTVPREIPCS (in Ref. 6;
FT                                AAW63121). {ECO:0000305}.
FT   CONFLICT    674    674       V -> L (in Ref. 2; AAD33397).
FT                                {ECO:0000305}.
SQ   SEQUENCE   880 AA;  97348 MW;  70E356773B148A8A CRC64;
     MQPGATTCTE DRIQHALERC LHGLSLSRRS TSWSAGLCLN CWSLQELVSR DPGHFLILLE
     QILQKTREVQ EKGTYDLLTP LALLFYSTVL CTPHFPPDSD LLLKAASTYH RFLTWPVPYC
     SICQELLTFI DAELKAPGIS YQRLVRAEQG LPIRSHRSST VTVLLLNPVE VQAEFLAVAN
     KLSTPGHSPH SAYTTLLLHA FQATFGAHCD VPGLHCRLQA KTLAELEDIF TETAEAQELA
     SGIGDAAEAR RWLRTKLQAV GEKAGFPGVL DTAKPGKLHT IPIPVARCYT YSWSQDSFDI
     LQEILLKEQE LLQPGILGDD EEEEEEEEEV EEDLETDGHC AERDSLLSTS SLASHDSTLS
     LASSQASGPA LSRHLLTSFV SGLSDGMDSG YVEDSEESSS EWPWRRGSQE RRGHRRPGQK
     FIRIYKLFKS TSQLVLRRDS RSLEGSSDTA LPLRRAGSLC SPLDEPVSPP SRAQRSRSLP
     QPKLGTQLPS WLLAPASRPQ RRRPFLSGDE DPKASTLRVV VFGSDRISGK VARAYSNLRR
     LENNRPLLTR FFKLQFFYVP VKRSHGTSPG ACPPPRSQTP SPPTDSPRHA SPGELGTTPW
     EESTNDISHY LGMLDPWYER NVLGLMHLPP EVLCQQSLKA EAQALEGSPT QLPILADMLL
     YYCRFAARPV LLQVYQTELT FITGEKTTEI FIHSLELGHS AATRAIKASG PGSKRLGIDG
     DREAVPLTLQ IIYSKGAISG RSRWSNLEKV CTSVNLNKAC RKQEELDSSM EALTLNLTEV
     VKRQNSKSKK GFNQISTSQI KVDKVQIIGS NSCPFAVCLD QDERKILQSV VRCEVSPCYK
     PEKSDLSSPP QTPPDLPAQA APDLCSLLCL PIMTFSGALP
//
